Consensus Albemarle Corporation

Stocks

ALB

US0126531013

Specialty Chemicals

Real-time Estimate Cboe BZX 20:59:49 16/10/2026 BST			5-day change	1st Jan Change
95.50 ^USD	-2.73%		-6.21%	-32.85%

10-15	RBC Cuts Price Target on Albemarle to $129 From $157, Keeps Outperform Rating	MT
10-14	Mizuho Securities Upgrades Albemarle to Buy From Neutral, $130 Price Target	MT

Evolution of the Average Target: Albemarle Corporation

Evolution of the Target Price: Albemarle Corporation

Changes in Analyst Recommendations: Albemarle Corporation

bfc4d11de6498.rCbbbIegsP9dvRuP3ZBlNGdTo0WOEKdq5ULOsz1MZMA._layFtfm140XzV26hdozfiI7kRXGWO4k3QCNxlM2HpmcfJEW9cfdkhLXVg~bcdce75a5faf869c3a4faeae51984535

Analysts' recommendations: Albemarle Corporation

10-15	RBC Cuts Price Target on Albemarle to $129 From $157, Keeps Outperform Rating	MT
10-14	Mizuho Securities Upgrades Albemarle to Buy From Neutral, $130 Price Target	MT
10-14	Baird Adjusts Price Target on Albemarle to $123 From $157	MT
10-14	Analyst recommendations: Albemarle, Dell Technologies, Domino's Pizza, Broadcom…
10-13	Barclays Initiates Albemarle at Equalweight With $109 Price Target	MT
10-06	BMO Capital Adjusts Price Target on Albemarle to $175 From $200, Keeps Outperform Rating	MT
10-05	UBS Adjusts Albemarle Price Target to $150 From $175, Maintains Buy Rating	MT
10-01	Mizuho Cuts Price Target on Albemarle to $130 From $140, Keeps Neutral Rating	MT
10-01	Mizuho Adjusts Price Target on Albemarle to $130 From $140, Maintains Neutral Rating	MT
09-18	Mizuho Securities Adjusts Albemarle Price Target to $140 From $160, Maintains Neutral Rating	MT
08-10	Albemarle to Benefit From Low-cost Assets, Brownfield Opportunity, RBC Says	MT
08-10	Scotiabank Adjusts Albemarle PT to $190 From $200, Maintains Sector Outperform Rating	MT
08-10	RBC Capital Adjusts Price Target on Albemarle to $157 From $166, Keeps Outperform Rating	MT
08-10	Morgan Stanley Adjusts Price Target on Albemarle to $161 From $189, Keeps Equalweight Rating	MT
08-07	Baird Adjusts Albemarle Price Target to $157 From $178	MT
08-07	Citigroup Adjusts Albemarle Price Target to $175 From $225	MT
08-07	BMO Capital Adjusts Albemarle Price Target to $200 From $250	MT
08-07	UBS Adjusts Price Target on Albemarle to $175 From $205, Maintains Buy Rating	MT
07-27	Scotiabank Adjusts Price Target on Albemarle to $200 From $215, Maintains Sector Outperform Rating	MT
07-23	HSBC Adjusts Price Target on Albemarle to $170 From $230, Maintains Buy Rating	MT
07-23	Analyst recommendations: Duke Energy, JPMorgan Chase, M&T Bank, Super Micro, Texas Instruments…
07-22	Analyst recommendations: Amcor, Coreweave, JPMorgan Chase, AMD, MetLife…
07-17	BofA Securities Adjusts Price Target on Albemarle to $155 From $225, Maintains Buy Rating	MT
07-17	RBC Cuts Price Target on Albemarle to $166 From $257, Keeps Outperform Rating	MT
07-09	UBS Adjusts Price Target on Albemarle to $205 From $264	MT

More recommendations

Other Specialty Chemicals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALBEMARLE CORPORATION					+64.77%
	ECOLAB INC.					+11.77%
	GIVAUDAN SA					-6.79%
	SIKA AG					+11.97%
	HENKEL AG & CO. KGAA					+0.57%
	NOVONESIS A/S					+9.02%
	FUJIFILM HOLDINGS CORPORATION					+17.78%
	EMS-CHEMIE HOLDING AG					-15.06%
	SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.					+37.08%
	DUPONT DE NEMOURS, INC.					+25.74%
	Average					+15.69%
	Weighted average by Cap.					+10.28%